Oasmia Pharmaceutical AB | Balance Sheet
Fiscal year is May-April. All values SEK Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
48,241.00
76,990.00
46,214.00
28,001.00
15,580.00
116,272
Total Accounts Receivable
2,807.00
2,672.00
6,832.00
1,425.00
36,731.00
7,496
Inventories
1,656.00
5,341.00
16,638.00
13,685.00
9,746.00
12,948
Other Current Assets
1,572.00
1,687.00
2,885.00
7,008.00
18,452.00
14,652
Total Current Assets
54,276.00
86,690.00
72,569.00
50,119.00
80,509.00
151,368
Net Property, Plant & Equipment
24,401.00
22,852.00
21,172.00
18,369.00
15,527.00
14,701
Total Investments and Advances
2.00
2.00
2.00
2.00
2.00
2,002
Intangible Assets
389,704.00
405,025.00
421,836.00
453,093.00
472,037.00
478,306
Other Assets
-
-
1.00
1.00
-
-
Total Assets
468,383.00
514,569.00
515,579.00
521,583.00
568,075.00
646,378
ST Debt & Current Portion LT Debt
145,000.00
107,000.00
139,944.00
168,726.00
187,260.00
Accounts Payable
17,503.00
14,017.00
27,236.00
20,837.00
9,256.00
Other Current Liabilities
23,081.00
17,841.00
22,346.00
31,649.00
26,523.00
Total Current Liabilities
185,584.00
138,858.00
189,526.00
221,212.00
223,039.00
Other Liabilities
892.00
-
-
-
-
Total Liabilities
186,476.00
138,858.00
189,526.00
221,212.00
223,039.00
Common Equity (Total)
281,907.00
375,711.00
326,053.00
300,371.00
345,042.00
Total Shareholders' Equity
281,907.00
375,711.00
326,053.00
300,371.00
345,042.00
Total Equity
281,907.00
375,711.00
326,053.00
300,371.00
345,036.00
Liabilities & Shareholders' Equity
468,383.00
514,569.00
515,579.00
521,583.00
568,075.00
Accumulated Minority Interest
-
-
-
-
6.00
About Oasmia Pharmaceutical AB
View Profile
